{"id":"CHEMBL107","canonicalSmiles":"COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2","inchiKey":"IAKHMKGGTNLKSZ-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COLCHICINE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Colchicine","Colcrys","Gloperba","Mitigare"],"synonyms":["(-)-colchicine","Colchcine","Colchicine","Colchicinum","Colchineos","Colchisol","NSC-757"],"crossReferences":{"DailyMed":["colchicine"],"PubChem":["104219585","11114044","144204498","144208745","144210899","170465011","17389095","17389096","26752175","26752176","49718107","50085974","50104821","50104822","50113684","50113685","50113686","67636","90340644"],"TG-GATEs":["113"],"Wikipedia":["Colchicine"],"chEBI":["27882"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000275","EFO_0003780","EFO_0004274","EFO_0000401","MONDO_0001370","EFO_1001129","EFO_1001486","EFO_0006803","EFO_0008585","EFO_0005240","EFO_0003144","EFO_0003884","EFO_0003938","EFO_0007427","EFO_0007541","MONDO_0004976","Orphanet_342","EFO_1001404","EFO_0008586","EFO_0000694","EFO_0004269","EFO_0000551","EFO_0001645","EFO_0003818","EFO_0005221","MONDO_0008315","EFO_0000537","EFO_0001422","EFO_0003863","EFO_0004220","MONDO_0100096","MONDO_0004979","EFO_0008583","EFO_0000612","MONDO_0005178","EFO_0005672","EFO_0004264"],"count":38},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for gout and familial mediterranean fever and has 31 investigational indications."}
{"id":"CHEMBL107430","canonicalSmiles":"CC1(C)CCC(C)(C)c2c1cc(C(=O)Nc1cc(F)c(C(=O)O)c(F)c1)c(O)c2Cl","inchiKey":"PNAWUIKCVQSLFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NRX195183","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN 195183","AGN-195183","IRX5183","Irx-5183","NRX-195183","NRX195183","Nrx195183","VTP-195183","VTP-5183"],"crossReferences":{"drugbank":["DB05653"]},"linkedTargets":{"rows":["ENSG00000131759"],"count":1},"linkedDiseases":{"rows":["EFO_0000224"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1079935","canonicalSmiles":"CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1","inchiKey":"NNAIYOXJNVGUOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPEROZIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amperozide"],"crossReferences":{"PubChem":["11110766","50110932","90340755"],"Wikipedia":["Amperozide"],"drugbank":["DB08927"]},"childChemblIds":["CHEMBL2092874","CHEMBL1257106"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL108877","canonicalSmiles":"Oc1ccccc1Cl","inchiKey":"ISPYQTSUDJAMAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-CHLOROPHENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Chloro-Phenol","2-Chlorophenol"],"crossReferences":{"PubChem":["144208608","144210658","17389669","85272560"],"Wikipedia":["2-Chlorophenol"],"drugbank":["DB03110"],"chEBI":["47083"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL112896","canonicalSmiles":"CCCCn1c(Cc2cc(OC)c(OC)c(OC)c2Cl)nc2c(N)ncnc21","inchiKey":"IVPCTHKPOPQMSX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL112896","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03504"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL113","canonicalSmiles":"Cn1c(=O)c2c(ncn2C)n(C)c1=O","inchiKey":"RYYVLZVUVIJVGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAFFEINE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nodoz","Nodoz caplets and chewable tablets","Pro-plus","Yeast-vite","Zanthine"],"synonyms":["Anhydrous caffeine","Cafcit","Caffeine","Caffeine anhydrous","Caffeine melting point standard","Caffeinum","Coffeine","Coffeinum","Durvitan","FEMA NO. 2224","Guaranine","Methyltheobromine","NSC-5036","Synalgos","Theine","Vivarin"],"crossReferences":{"DailyMed":["caffeine","caffeine%20citrate"],"PubChem":["104171124","11110908","124879556","144208883","144210330","17389997","26732615","26752751","49718178","50105397","50105398","90341215"],"TG-GATEs":["97"],"Wikipedia":["Caffeine","Caffeine_(data_page)"],"drugbank":["DB00201"],"chEBI":["27732"]},"childChemblIds":["CHEMBL1200569"],"linkedTargets":{"rows":["ENSG00000282608","ENSG00000170425","ENSG00000128271","ENSG00000163485"],"count":4},"linkedDiseases":{"rows":["MONDO_0004938","EFO_0000729","EFO_0002610","EFO_0000275","MONDO_0004567","EFO_1001919","HP_0012228","HP_0001298","EFO_0003914","EFO_0003925","EFO_0000676","HP_0003419","MONDO_0004976","HP_0002104","EFO_0003888","HP_0012532","EFO_0003035","EFO_0002687","EFO_0000384","MONDO_0008315","MONDO_0100431","EFO_0005741","HP_0030833","EFO_0005109","HP_0100607","EFO_1001158","MONDO_0021107","MONDO_0000726","EFO_0005252","EFO_1001249","EFO_0000274","EFO_0003876","EFO_0000305","EFO_0600064","MONDO_0005277","Orphanet_68380","EFO_0009444","MONDO_0005180","EFO_0004272","EFO_0003917","MONDO_0007079","EFO_0002617","EFO_0000616","HP_0002094","EFO_0000685","EFO_0001645","MONDO_0001020","EFO_0009692","EFO_0003929","HP_0003418","EFO_0001073","EFO_0003843","HP_0002315","EFO_0007214","EFO_0001072","EFO_0004220","EFO_0000764","EFO_0001421","MONDO_0004975","MONDO_0005148","MONDO_0005475"],"count":61},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and has 4 approved and 50 investigational indications."}
{"id":"CHEMBL1148","canonicalSmiles":"Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1","inchiKey":"NGBFQHCMQULJNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TORSEMIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Demadex","Soaanz","Torem 10","Torem 2.5","Torem 5","Torsemide"],"synonyms":["AC-4464","AC4464","BM-02.015","BM-02015","BM02.015","Luprac","Torasemide","Torasemide anhydrous","Torsemide","Upcard"],"crossReferences":{"DailyMed":["torsemide"],"PubChem":["11112793","144204213","170465279","26719820","26748988","49665992","49666477"],"Wikipedia":["Torasemide"],"drugbank":["DB00214"],"chEBI":["9637"]},"linkedTargets":{"rows":["ENSG00000074803"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000712","EFO_0000373","EFO_0000319","EFO_0000612","MONDO_0005148","EFO_0000668","EFO_0000537"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 6 approved and 2 investigational indications."}
{"id":"CHEMBL1163","canonicalSmiles":"COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C","inchiKey":"AXRYRYVKAWYZBR-GASGPIRDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATAZANAVIR","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Reyataz"],"synonyms":["Atazanavir","BMS-232632","CGP-73547"],"crossReferences":{"DailyMed":["atazanavir%20sulfate"],"PubChem":["144206632","170465290"],"Wikipedia":["Atazanavir"],"drugbank":["DB01072"],"chEBI":["37924"]},"childChemblIds":["CHEMBL1200678"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 4 approved and 6 investigational indications."}
{"id":"CHEMBL1200449","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)[C@H](OC(C)=O)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"XGMPVBXKDAHORN-RBWIMXSLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIAMCINOLONE DIACETATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aristocort","Kenacort","Triamcinolone diacetate"],"synonyms":["Aristocort forte","NSC-757356","Orion","Polcortolon","Tedarol","Triamcinolone 16,21-diacetate","Triamcinolone diacetate"],"crossReferences":{"PubChem":["144206670","170464837"],"chEBI":["9669"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0009552","HP_0001742","EFO_0005752","EFO_0002950"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 4 approved indications."}
{"id":"CHEMBL1200503","canonicalSmiles":"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O","inchiKey":"NOJMTMIRQRDZMT-GSPXQYRGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMOCRIPTINE MESYLATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL493","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bromocriptine mesylate","Cycloset","Parlodel"],"synonyms":["2-bromoergocryptine mesylate","Bromocriptine mesilate","Bromocriptine mesylate","Bromocriptine methanesulfonate","CB-154","CB-154 MESYLATE","Cb-154 mesilate","NSC-755915"],"crossReferences":{"DailyMed":["bromocriptine%20mesylate"],"PubChem":["144213902","442420","50105911"],"chEBI":["3182"]},"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0000545","EFO_1001485","MONDO_0005180","EFO_0007319","EFO_0000232","MONDO_0005148","MONDO_0001299"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 7 approved indications."}
{"id":"CHEMBL1200545","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"BOBLHFUVNSFZPJ-JOYXJVLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFLORASONE DIACETATE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diflorasone diacetate","Florone","Florone e","Psorcon","Psorcon e"],"synonyms":["Diflorasone","Diflorasone diacetate","Murode","U-34,865","U-34865"],"crossReferences":{"DailyMed":["diflorasone%20diacetate"],"PubChem":["144204426","170465294","29215002","56422226","855657"],"chEBI":["31483"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000701"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977 and is indicated for skin disease."}
{"id":"CHEMBL1200548","drugType":"Small molecule","blackBoxWarning":false,"name":"MANGANESE CHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200693","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lumenhance"],"synonyms":["CMC-001","CMC001","Manganese (as chloride)","Manganese chloride","Manganese chloride tetrahydrate","Manganous chloride","Manganous chloride tetrahydrate","Manganum muriaticum","Mangoral","NSC-9879"],"crossReferences":{"DrugCentral":["4521"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 4 investigational indications."}
{"id":"CHEMBL1200554","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O","inchiKey":"ZBVJFYPGLGEMIN-OYLNGHKZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TRIPTORELIN PAMOATE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201334","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trelstar","Triptodur kit"],"synonyms":["Salvacyl","Triptorelin (as embonate)","Triptorelin embonate","Triptorelin pamoate"],"crossReferences":{"DailyMed":["triptorelin%20pamoate"]},"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0009029","EFO_0001065","MONDO_0000088","MONDO_0007254","EFO_0000673","MONDO_0008315","EFO_0001663"],"count":7},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 4 approved and 3 investigational indications."}
{"id":"CHEMBL1200901","canonicalSmiles":"CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12.Cl","inchiKey":"WANGFTDWOFGECH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOFANTRINE HYDROCHLORIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1107","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Halfan"],"synonyms":["Halofantrine hcl","Halofantrine hydrochloride","SKF-102886","WR-171669"],"crossReferences":{"PubChem":["144204188","170465140","56463552"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992."}
{"id":"CHEMBL1201082","canonicalSmiles":"CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1.Cl","inchiKey":"GIYXAJPCNFJEHY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUOXETINE HYDROCHLORIDE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL41","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Felicium","Fluoxetine","Fluoxetine hydrochloride","Olena","Oxactin","Prozac","Prozac 60","Prozac weekly","Prozep","Prozit","Ranflutin","Sarafem","Selfemra"],"synonyms":["Adofen","Fluctin","Fluneurin","Fluox-puren","Fluoxeren","Fluoxetine (as hydrochloride)","Fluoxetine hydrochloride","Flusol","Fluxet","Fontex","Foxetin","LY-110140","LY110140","Lovan","Reconcile"],"crossReferences":{"DailyMed":["fluoxetine%20hydrochloride"],"PubChem":["144207380","26747522","26747523","50106352","50106353","50106354","56422172","855820"]},"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["EFO_0000289","MONDO_0002050","EFO_0004262","MONDO_0002009","EFO_0003761","EFO_0009963","EFO_0004242"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 5 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201471","drugType":"Unknown","blackBoxWarning":false,"name":"HYDROXYPROPYL CELLULOSE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lacrisert"],"synonyms":["E463","Hydroxypropyl cellulose"],"crossReferences":{"DailyMed":["hydroxypropyl%20cellulose"],"Wikipedia":["Hydroxypropyl_cellulose"]},"description":"Unknown drug with a maximum clinical trial phase of IV and is indicated for keratoconjunctivitis."}
{"id":"CHEMBL1201488","drugType":"Protein","blackBoxWarning":false,"name":"SECRETIN SYNTHETIC HUMAN","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chirhostim"],"synonyms":["Human secretin","Secretin (human)","Secretin (human), acetate (salt)","Secretin Synthetic Human","Secretin acetate human","Secretin human","Secretin human acetate","Secretin human pentaacetate","Secretin synthetic human","Synthetic human secretin"],"crossReferences":{"DailyMed":["secretin%20synthetic%20human"]},"linkedTargets":{"rows":["ENSG00000080293"],"count":1},"linkedDiseases":{"rows":["EFO_0003758","EFO_0004242"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 2 investigational indications."}
{"id":"CHEMBL1201641","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP EXTENDED RECOMBINANT HUMAN","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Humulin u"],"synonyms":["Insulin zinc susp extended recombinant human"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1987."}
{"id":"CHEMBL1201661","drugType":"Protein","blackBoxWarning":false,"name":"CALCITONIN SALMON RECOMBINANT","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fortical"],"synonyms":["Calcitonin (salmon synthetic)","Calcitonin salmon recombinant"],"crossReferences":{"DailyMed":["calcitonin%20salmon%20recombinant"]},"linkedTargets":{"rows":["ENSG00000004948"],"count":1},"linkedDiseases":{"rows":["HP_0000938","EFO_0003854","EFO_0003882","EFO_0005754"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for postmenopausal osteoporosis and parathyroid disease and has 2 investigational indications."}
{"id":"CHEMBL1201780","canonicalSmiles":"NC(=O)N[C@@H](CCC(=O)O)C(=O)O","inchiKey":"LCQLHJZYVOQKHU-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARGLUMIC ACID","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carbaglu"],"synonyms":["Carglumic acid","N-carbamyl-l-glutamic acid","NSC-760124","OE 312","OE 312 (LABORATORY CODE DESIGNATION)","OE-312"],"crossReferences":{"DailyMed":["carglumic%20acid"],"PubChem":["144206097","170466164"],"Wikipedia":["Carglumic_acid"],"drugbank":["DB06775"],"chEBI":["71028"]},"linkedTargets":{"rows":["ENSG00000021826"],"count":1},"linkedDiseases":{"rows":["MONDO_0002012","Orphanet_35","Orphanet_68367","Orphanet_927","HP_0001987"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for hyperammonemia due to n-acetylglutamate synthetase deficiency and hyperammonemia and has 2 investigational indications."}
{"id":"CHEMBL120643","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CCC1(C)CCc2cc(O)ccc2O1","inchiKey":"GJJVAFUKOBZPCB-ZGRPYONQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL120643","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124897770"],"drugbank":["DB12647"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1207374","canonicalSmiles":"O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"GRSZFWQUAKGDAV-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1207374","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26754274"],"drugbank":["DB04566"],"chEBI":["17202"]},"childChemblIds":["CHEMBL1627077"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1213252","canonicalSmiles":"O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O","inchiKey":"XDDJGVMJFWAHJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLORAZEPIC ACID","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["4306-CB FREE ACID","ABBOTT-35616 FREE ACID","Chlorazepate","Clorazepate","Clorazepic acid"],"crossReferences":{"DailyMed":["clorazepate%20dipotassium"],"drugbank":["DB00628"],"chEBI":["3761"]},"childChemblIds":["CHEMBL2096631","CHEMBL2106085"],"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000163285","ENSG00000113327","ENSG00000151834","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0006788","HP_0001250","EFO_0005230"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and is indicated for anxiety disorder and seizure and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1229651","canonicalSmiles":"Cc1cccc2c1C(=O)N(c1ccnc(Cl)c1)C2=O","inchiKey":"YDJMWNHJNJVVMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229651","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06860"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232369","canonicalSmiles":"NC(=O)C[C@@H](N)C(=O)O","inchiKey":"DCXYFEDJOCDNAF-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232369","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756685"],"drugbank":["DB03943"],"chEBI":["28159"]},"childChemblIds":["CHEMBL2361922"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232510","canonicalSmiles":"CC[C@H]1OC(=O)[C@@](C)(F)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cc(-c4cccc(N)c4)nn3)C(=O)O[C@]12C","inchiKey":"IXXFZUPTQVDPPK-ZAWHAJPISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOLITHROMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CEM 101","CEM-101","OP 1068","OP-1068","Solithromycin"],"crossReferences":{"drugbank":["DB09308"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1232960","canonicalSmiles":"O=C(O)c1conc1O","inchiKey":"JLPHBZYAQYOJND-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232960","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02111"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233598","canonicalSmiles":"N=C1N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]2N1","inchiKey":"WWVANQJRLPIHNS-ZKWXMUAHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-IMINOBIOTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-iminobiotin","Guanidinobiotin"],"crossReferences":{"drugbank":["DB03353"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1236395","canonicalSmiles":"OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"HDTRYLNUVZCQOY-LIZSDCNHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TREHALOSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.,.alpha.-trehalose","Cabaletta","Mushroom sugar","Mycose","NSC-2093","Trehalose"],"crossReferences":{"Wikipedia":["Trehalose"],"drugbank":["DB12310"],"chEBI":["16551"]},"childChemblIds":["CHEMBL3188936"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1332546","canonicalSmiles":"CCC(C(=O)OCCOCCN(CC)CC)c1ccccc1","inchiKey":"DDVUMDPCZWBYRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTAMIRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butamirate","Codimin"],"crossReferences":{"PubChem":["26660763","29216339"],"drugbank":["DB13731"]},"childChemblIds":["CHEMBL2106133"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1337","canonicalSmiles":"O=C1CCCC(=O)C1C(=O)c1ccc(C(F)(F)F)cc1[N+](=O)[O-]","inchiKey":"OUBCNLGXQFSTLU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITISINONE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nityr","Orfadin"],"synonyms":["Nitisinone","SC-0735"],"crossReferences":{"DailyMed":["nitisinone"],"PubChem":["174007248"],"Wikipedia":["Nitisinone"],"drugbank":["DB00348"],"chEBI":["50378"]},"linkedTargets":{"rows":["ENSG00000158104"],"count":1},"linkedDiseases":{"rows":["Orphanet_56","MONDO_0043209","MONDO_0004741","HP_0000572"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 3 investigational indications."}
{"id":"CHEMBL1380","canonicalSmiles":"Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1","inchiKey":"MCGSCOLBFJQGHM-SCZZXKLOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ABACAVIR","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ziagen"],"synonyms":["Abacavir","Avacavir","Epzicom","NSC-742406","Ziagen"],"crossReferences":{"DailyMed":["abacavir%20sulfate"],"PubChem":["26757979"],"Wikipedia":["Abacavir"],"drugbank":["DB01048"],"chEBI":["421707"]},"childChemblIds":["CHEMBL4303288","CHEMBL1200619","CHEMBL2106686"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 3 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1417019","canonicalSmiles":"Cl.Cl.O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21","inchiKey":"ZAHQPTJLOCWVPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MITOXANTRONE HYDROCHLORIDE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL58","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mitoxantrone hydrochloride","Novantrone"],"synonyms":["CL 232,315","CL-232315","Mitoxantrone Dihcl","Mitoxantrone Dihydrochloride","Mitoxantrone dihydrochloride","Mitoxantrone hcl","Mitoxantrone hydrochloride","Mitozantrone","NSC-301739"],"crossReferences":{"PubChem":["144203748","170465183","26747571","26747572","26747573","50106605"],"chEBI":["50727"]},"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0011061","MONDO_0007254","EFO_1001469","EFO_0005952","EFO_1001052","MONDO_0003541","EFO_0000565","EFO_0000178","EFO_0004251","EFO_0000339","MONDO_0019460","EFO_1001830","EFO_0004289","EFO_0000673","EFO_0000196","EFO_0000330","EFO_0000182","MONDO_0020743","EFO_0008522","EFO_0000198","EFO_0000616","EFO_0006859","EFO_0000220","MONDO_0019457","MONDO_0008170","EFO_0000403","EFO_0000222","EFO_0003929","EFO_1000286","EFO_0000224","MONDO_0008315","EFO_0003843","EFO_0001663","EFO_0000311","EFO_0000211","MONDO_0001023","MONDO_0005301","EFO_0000095","MONDO_0019472","EFO_0000574","EFO_0004256","MONDO_0018906","EFO_0001378"],"count":44},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 5 approved and 34 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1418176","canonicalSmiles":"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O","inchiKey":"XWALNWXLMVGSFR-HLXURNFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHANDROSTENOLONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Germany"," France"],"classes":["Misuse"],"year":1982},"tradeNames":["Dianabol"],"synonyms":["Metandienone","Methandienone","Methandrostenolone","NSC-42722","Nerobol","Perbolin"],"crossReferences":{"PubChem":["144205200","170466069","29215353"],"Wikipedia":["Methandrostenolone"],"drugbank":["DB13586"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom,  United States,  Germany and  France initially in 1982 due to Misuse."}
{"id":"CHEMBL1596","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)Oc3ccc4c(c3)CCC4)c3ccccc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"JIRBAUWICKGBFE-MNRDOXJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENICILLIN INDANYL","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carbenicillin indanyl","Carindacillin","Indanyl carbenicillin"],"crossReferences":{"PubChem":["144206652","50126360"],"drugbank":["DB09319"],"chEBI":["52015"]},"childChemblIds":["CHEMBL1200991"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1604375","canonicalSmiles":"COP(=S)(OC)Oc1ccc(SC)c(C)c1","inchiKey":"PNVJTZOFSHSLTO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENTHION","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Pro-spot","Spotton","Tiguvon"],"synonyms":["Fenthion","NSC-755881"],"crossReferences":{"PubChem":["144204708","144208793","144210975","170466807","17389877","26753078","89854991"],"drugbank":["DB11412"],"chEBI":["34761"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1654","canonicalSmiles":"O=P([O-])(O)C(O)(Cc1cccnc1)P(=O)(O)O.[Na+]","inchiKey":"DRFDPXKCEWYIAW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"RISEDRONATE SODIUM","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL923","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actonel","Atelvia","Risedronate sodium"],"synonyms":["NE-58095","NE-58095 ANHYDROUS","NSC-722598","NSC-759280","Risedronate monosodium","Risedronate sodium","Risedronate sodium anhydrous","Risedronic acid monosodium salt"],"crossReferences":{"DailyMed":["risedronate%20sodium"],"PubChem":["174006918"]},"linkedTargets":{"rows":["ENSG00000160752"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0003854","EFO_0003957","MONDO_0007254","EFO_0000574","Orphanet_666","EFO_0003882","EFO_0004215","MONDO_0021165"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL1671","canonicalSmiles":"CC(C)NCC(O)COc1cccc2ccccc12.Cl","inchiKey":"ZMRUPTIKESYGQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROPRANOLOL HYDROCHLORIDE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL27","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Angilol","Apsolol","Avlocardyl","Bedranol","Bedranol s.r.","Berkolol","Beta-prograne mr","Betadur cr","Cardinol","Dupromex","Half beta-prograne mr","Half propanix la","Half propatard la","Half-beprane cr","Half-betadur cr","Half-inderal la","Hemangeol","Inderal","Inderal la","Innopran","Innopran xl","Lederpronol","Lopranol la","Probeta la","Propanix la","Propanix-10","Propanix-160","Propanix-160 sr","Propanix-40","Propanix-80","Propatard la","Propranolol hydrochloride","Propranolol hydrochloride intensol","Rapranol sr","Sagittol","Slo-blok","Slo-pro","Sloprolol","Syprol","Tesnol"],"synonyms":["AY 64043","AY-64043","ICI 45520","ICI-45520","NSC-91523","Propranolol hydrochloride"],"crossReferences":{"DailyMed":["propranolol%20hydrochloride"],"PubChem":["144209084","144213222","17389750","26732618","26747603","26747604","26751803","46500341","50106744","50106745","50106746"],"chEBI":["8500"]},"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0002610","EFO_0004280","EFO_0004269","HP_0001636","EFO_0001358","EFO_1001968","EFO_0001073","EFO_0001663","EFO_0000537","EFO_0003913","MONDO_0001187","MONDO_0005277","EFO_0001422","EFO_0009444","EFO_1001450","EFO_0003860","MONDO_0021661","EFO_0000389","EFO_0000712","EFO_0004142","EFO_0009545","MONDO_0043510","MONDO_0005148","EFO_1000635"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and has 7 approved and 14 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1672973","canonicalSmiles":"Cc1cc(-c2ccccc2[C@@H](C)OC[C@H](O)CNC(C)(C)Cc2ccc(Cl)c(F)c2)ccc1C(=O)O","inchiKey":"UNFHDRVFEQPUEL-DENIHFKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCALERET","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Encaleret","JTT-305"],"childChemblIds":["CHEMBL2105731"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1697759","canonicalSmiles":"O=C(NCN1CCOCC1)c1cnccn1","inchiKey":"GVTLAVKAVSKBKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORINAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["B-2311","Morinamide","Morinamide hcl","Morinamide hydrochloride","Morphazinamide","Morphazinamide hydrochloride","Piazofolina"],"crossReferences":{"PubChem":["144205376","170466494","50085443"],"drugbank":["DB13417"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1708","canonicalSmiles":"Cl.Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1","inchiKey":"GELRVIPPMNMYGS-RVXRQPKJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PAROXETINE HYDROCHLORIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL490","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paroxetine hydrochloride","Paxil","Paxil cr","Seroxat"],"synonyms":["NSC-758654","Paroxetine HCl","Paroxetine hydrochloride","Paroxetine hydrochloride anhydrous"],"crossReferences":{"DailyMed":["paroxetine%20hydrochloride"],"PubChem":["26753519","85273719"]},"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["EFO_0004262","MONDO_0002050","EFO_0006788","MONDO_0002009","EFO_0001645","EFO_0003761","EFO_0001358","EFO_1001917","EFO_0004242","EFO_0005230","EFO_0003922"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 8 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1743039","drugType":"Antibody","blackBoxWarning":false,"name":"MAVRILIMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CAM-3001","CAM3001","KPL-301","Mavrilimumab"],"linkedTargets":{"rows":["ENSG00000198223","ENSG00000100368"],"count":2},"linkedDiseases":{"rows":["EFO_1001209","EFO_0000685","MONDO_0100096"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1788386","canonicalSmiles":"CC(C)=CC1C(C(=O)OCN2C(=O)C3=C(CCCC3)C2=O)C1(C)C","inchiKey":"CXBMCYHAMVGWJQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAMETHRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tetramethrin"],"crossReferences":{"PubChem":["50113148"],"drugbank":["DB13752"],"chEBI":["39397"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1906890","canonicalSmiles":"CC[C@H]1CN2CCC1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12","inchiKey":"LJOQGZACKSYWCH-NBGVHYBESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROQUINIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dihydroquinidine","Hydroconchinine","Hydroquinidine","NSC-757410"],"crossReferences":{"chEBI":["5792"]},"childChemblIds":["CHEMBL1893843"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1908391","canonicalSmiles":"Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1","inchiKey":"WJEOLQLKVOPQFV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MASITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Kinavet","Masivet"],"synonyms":["AB-1010","AB1010","Ab-1010","Masican","Masitinib","Masitinib mesilate","Masitinib mesylate","Masitinib methanesulfonate","Masiviera"],"crossReferences":{"PubChem":["124950163","99460877"],"drugbank":["DB11526"],"chEBI":["63450"]},"linkedTargets":{"rows":["ENSG00000134853","ENSG00000068078","ENSG00000113721","ENSG00000157404"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_0000685","MONDO_0008170","Orphanet_44890","MONDO_0016586","EFO_0009001","MONDO_0008315","EFO_1001480","EFO_0003840","MONDO_0100096","MONDO_0005301","MONDO_0004975","EFO_0000676","MONDO_0004979","EFO_0001378","MONDO_0004976","EFO_0002617"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 17 investigational indications."}
{"id":"CHEMBL1927030","canonicalSmiles":"CN[C@H](C)Cc1ccccc1","inchiKey":"MYWUZJCMWCOHBA-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVMETAMFETAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-desoxyephedrine","L-methamphetamine","Levmetamfetamine","Levmetamfetamine cii","Levomethamphetamine"],"crossReferences":{"drugbank":["DB09571"]},"childChemblIds":["CHEMBL3189065"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2052016","canonicalSmiles":"C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CCC(=O)O)c(CCC(=O)OC)c4C)[C@@]1(C)C3=CC=C(C(=O)OC)[C@H]1C(=O)OC","inchiKey":"YTZALCGQUPRCGW-MXVXOLGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2052016","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB00460"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2063215","canonicalSmiles":"N#Cc1ccc(Oc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)cc1","inchiKey":"QIBWSQJZKMUZAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SC-43","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SC 43","SC-43","Sc-43"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL21","canonicalSmiles":"Nc1ccc(S(N)(=O)=O)cc1","inchiKey":"FDDDEECHVMSUSB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFANILAMIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sulfanilamide"],"synonyms":["Aniline-p-sulfonic amide","NSC-7618","P-aminobenzenesulfamide","P-aminobenzenesulfonamide","Prontosil i","Prontylin","Streptocid","Sulfamine","Sulfanilamide","Sulfonamide","Sulphanilamidum"],"crossReferences":{"PubChem":["11112170","144203902","144208529","144213653","170464653","17389527","47193670"],"Wikipedia":["Sulfanilamide"],"drugbank":["DB00259"],"chEBI":["45373"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and is indicated for bacterial disease."}
{"id":"CHEMBL2103739","canonicalSmiles":"CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O","inchiKey":"FWLKKPKZQYVAFR-LVEZLNDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMEDASTINE DIFUMARATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL594","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emadine"],"synonyms":["AL-3432A","Emedastine difumarate","Emedastine fumarate","KB-2413","LY-188695","Ly188695","Rapimine"],"crossReferences":{"PubChem":["144206353","170465197"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997."}
{"id":"CHEMBL2103810","canonicalSmiles":"CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c1ccccc1.Cl","inchiKey":"XJDYQYNYISTAMO-GFDYFVENSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EZATIOSTAT HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110585","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Telintra"],"synonyms":["Ezatiostat hcl","Ezatiostat hydrochloride","TER-199","TER199","TLK-199 HYDROCHLORIDE","TLK199"],"linkedTargets":{"rows":["ENSG00000084207"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0001475","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104153","canonicalSmiles":"CC(CN(C)C)CN1c2ccccc2Sc2ccc(C#N)cc21","inchiKey":"SLFGIOIONGJGRT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYAMEMAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyamemazine","Cyamepromazine","FL-6229","Kyamepromazin","RP 7204","RP-7204","TH-2602","Tercian"],"crossReferences":{"drugbank":["DB09000"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104254","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCOCCO)CC1","inchiKey":"KJTKYGFGPQSRRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOXERIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbetidine","Etoxeridine","IDS-NE-008","UCB 2073","UCB-2073","WY-2039"],"crossReferences":{"drugbank":["DB01505"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104722","canonicalSmiles":"N=C(NC(=N)N1CCN(C(=N)NC(=N)Nc2ccc(Cl)cc2)CC1)Nc1ccc(Cl)cc1","inchiKey":"YNCLPFSAZFGQCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICLOXYDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Picloxydine"],"crossReferences":{"drugbank":["DB13607"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105002","canonicalSmiles":"CC(CC(C#N)(c1ccccc1)C(C)C)N(C)C","inchiKey":"WFLSCFISQHLEED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOAMINILE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dimyril"],"synonyms":["2c-b-an","Isoaminile","Isoaminile citrate","Perocan"],"crossReferences":{"PubChem":["170465846"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cough."}
{"id":"CHEMBL2106198","canonicalSmiles":"CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1","inchiKey":"PYMDEDHDQYLBRT-DRIHCAFSSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BUSERELIN ACETATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2110824","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Suprefact"],"synonyms":["Buserelin acetate","Buserelin monoacetate","Conceptal","HOE 766","HOE-766","NSC-725176"],"crossReferences":{"chEBI":["31324"]},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2106261","canonicalSmiles":"CCOC(=O)C(c1c(O)c2ccccc2oc1=O)c1c(O)c2ccccc2oc1=O","inchiKey":"JCLHQFUTFHUXNN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYL BISCOUMACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethyl biscoumacetate","Ethyl biscumacetate","Ethyldicoumarol","NSC-36366","Neodicumarinum","Neodicumarol","Pelentan","Stabilene","Trombarin","Tromexan"],"crossReferences":{"PubChem":["170466152"],"drugbank":["DB08794"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106997","canonicalSmiles":"CCC(c1ccccc1)c1noc(CCN(CC)CC)n1","inchiKey":"OLTAWOVKGWWERU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROXAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aerbron"],"synonyms":["Propoxaline","Proxazole"],"crossReferences":{"drugbank":["DB13819"]},"childChemblIds":["CHEMBL2104858"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108985","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"APRINOCARSEN SODIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Affinitak"],"synonyms":["Aprinocarsen nonadecasodium salt","Aprinocarsen sodium","ISIS 5321","ISIS-5321"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109163","drugType":"Unknown","blackBoxWarning":false,"name":"HEPATITIS B VIRUS VACCINE INACTIVATED","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Engerix-b","H-b-vax","Heptavax-b"],"synonyms":["Hepatitis b virus vaccine inactivated"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109327","drugType":"Antibody","blackBoxWarning":false,"name":"CSL-360","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CSL-360","Csl-360"],"linkedTargets":{"rows":["ENSG00000185291"],"count":1},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109429","drugType":"Antibody","blackBoxWarning":false,"name":"RG-7686","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-7686"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109498","drugType":"Antibody","blackBoxWarning":false,"name":"IPH-2101","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-7F9","IHP-2101","IPH-2101","IPH2101","Iph-2101"],"linkedTargets":{"rows":["ENSG00000125498","ENSG00000276011","ENSG00000243772"],"count":3},"linkedDiseases":{"rows":["EFO_0000222","EFO_0001378"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2110581","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@@H]3[C@@H](COP(=O)(O)O[C@@H]4[C@@H](COP(=O)(O)O[C@@H]5[C@@H](COP(=O)(O)O[C@@H]6[C@@H](COP(=O)(O)O[C@@H]7[C@@H](COP(=O)(O)O[C@@H]8[C@@H](COP(=O)(O)O[C@@H]9[C@@H](COP(=O)(O)O[C@@H]%10[C@@H](COP(=O)(O)O[C@@H]%11[C@@H](COP(=O)(O)O[C@@H]%12[C@@H](COP(=O)(O)O[C@@H]%13[C@@H](COP(=O)(O)O[C@@H]%14[C@@H](COP(=O)(O)O[C@@H]%15[C@@H](COP(=O)(O)O[C@@H]%16[C@@H](COP(=O)(O)O[C@@H]%17[C@@H](COP(=O)(O)O[C@@H]%18[C@@H](COP(=O)(O)O[C@@H]%19[C@@H](COP(=O)(O)O[C@@H]%20[C@@H](COP(=O)(O)O[C@@H]%21[C@@H](CO)O[C@@H](n%22cnc%23c(N)ncnc%23%22)[C@@H]%21O)O[C@@H](n%21ccc(N)nc%21=O)[C@@H]%20O)O[C@@H](n%20ccc(N)nc%20=O)[C@@H]%19O)O[C@@H](n%19ccc(=O)[nH]c%19=O)[C@@H]%18O)O[C@@H](n%18ccc(N)nc%18=O)[C@@H]%17O)O[C@@H](n%17cnc%18c(N)ncnc%18%17)[C@@H]%16O)O[C@@H](n%16ccc(N)nc%16=O)[C@@H]%15O)O[C@@H](n%15ccc(N)nc%15=O)[C@@H]%14O)O[C@@H](n%14cnc%15c(N)ncnc%15%14)[C@@H]%13O)O[C@@H](n%13cnc%14c(N)ncnc%14%13)[C@@H]%12O)O[C@@H](n%12cnc%13c(=O)[nH]c(N)nc%13%12)[C@@H]%11O)O[C@@H](n%11cnc%12c(=O)[nH]c(N)nc%12%11)[C@@H]%10O)O[C@@H](n%10ccc(N)nc%10=O)[C@@H]9O)O[C@@H](n9ccc(N)nc9=O)[C@@H]8O)O[C@@H](n8cnc9c(N)ncnc98)[C@@H]7O)O[C@@H](n7cnc8c(=O)[nH]c(N)nc87)[C@@H]6O)O[C@@H](n6ccc(N)nc6=O)[C@@H]5O)O[C@@H](n5cnc6c(N)ncnc65)[C@@H]4O)O[C@@H](n4ccc(N)nc4=O)[C@@H]3O)O2)c(=O)[nH]c1=O","inchiKey":"PRYZSLKPMFOUNL-MHIBGBBJSA-N","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"BEVASIRANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bevasiranib"],"childChemblIds":["CHEMBL2103797"],"linkedTargets":{"rows":["ENSG00000164342"],"count":1},"linkedDiseases":{"rows":["EFO_0009606","EFO_0001365","EFO_0009321"],"count":3},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL212301","canonicalSmiles":"N=C(N)NCCC[C@@H](N)C(=O)O","inchiKey":"ODKSFYDXXFIFQN-SCSAIBSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-Arginine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Arginine"],"crossReferences":{"PubChem":["26754410","26754411"],"Wikipedia":["Arginine"],"drugbank":["DB04027"],"chEBI":["15816"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146110","canonicalSmiles":"Cl.Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1","inchiKey":"QDLVYMYXOLGZOD-ZMBIFBSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARIZOTAN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL220808","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD 128130","EMD-128130","Emd128130","Sarizotan hcl","Sarizotan hydrochloride"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000149295","ENSG00000069696","ENSG00000151577"],"count":4},"linkedDiseases":{"rows":["EFO_0004280","MONDO_0005180"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL222440","canonicalSmiles":"O=C(O)c1cc(Oc2ccc(C(F)(F)F)cc2Cl)ccc1[N+](=O)[O-]","inchiKey":"NUFNQYOELLVIPL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACIFLUORFEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acifluorfen"],"crossReferences":{"PubChem":["144209037","144211077","26757299","29216446","47193733"],"Wikipedia":["Acifluorfen"],"drugbank":["DB07338"],"chEBI":["73172"]},"childChemblIds":["CHEMBL3184255"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL225111","canonicalSmiles":"CC(C)=CCC[C@@H](C)[C@H]1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)C(C)(C)[C@@H]1CC3","inchiKey":"CAHGCLMLTWQZNJ-BQNIITSRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANOSTEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lanostereol"],"crossReferences":{"PubChem":["26757817"],"Wikipedia":["Lanosterol"],"drugbank":["DB03696"],"chEBI":["16521"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2312181","canonicalSmiles":"CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4)oc23)C1CO","inchiKey":"HRTOUPQLDWWXIX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"P-276-00","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P 276-00","P-276-00","P-27600"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL232566","canonicalSmiles":"O=C(NCCNC(=O)c1ccc(Cl)s1)c1ccc(-n2ccccc2=O)cc1","inchiKey":"UCKHUNHXYMAFQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL232566","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08173"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL23552","canonicalSmiles":"O=P(O)(O)O[C@H]1[C@@H](O)[C@@H](OP(=O)(O)O)[C@H](O)[C@@H](OP(=O)(O)O)[C@@H]1OP(=O)(O)O","inchiKey":"CIPFCGZLFXVXBG-CNWJWELYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Ionositol 1,3,4,5-Tetraphosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ionositol 1,3,4,5-Tetraphosphate"],"crossReferences":{"drugbank":["DB01863"],"chEBI":["16783"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2365680","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(CCc2cccs2)CC1C","inchiKey":"SRARDYUHGVMEQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2365680","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01439"],"chEBI":["53763"]},"childChemblIds":["CHEMBL2362021"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL275661","canonicalSmiles":"O=C1CCC(=O)N1","inchiKey":"KZNICNPSHKQLFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUCCINIMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Succinimide"],"crossReferences":{"Wikipedia":["Succinimide"],"drugbank":["DB13376"],"chEBI":["9307"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL293776","canonicalSmiles":"COc1c(O)cc2oc(-c3ccc(O)cc3)cc(=O)c2c1O","inchiKey":"IHFBPDAQLQOCBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HISPIDULIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-122415","TCMDC-123942"],"crossReferences":{"PubChem":["26725244","416148","50112864"],"drugbank":["DB14008"],"chEBI":["75902"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL304858","canonicalSmiles":"C=CCN(C)CCCCCCOc1ccc(C(=O)c2ccc(Br)cc2)c(F)c1","inchiKey":"CMYCCJYVZIMDFU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL304858","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124893195","29217636"],"drugbank":["DB02016"]},"childChemblIds":["CHEMBL324162"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL310555","canonicalSmiles":"Oc1cccc2cccnc12","inchiKey":"MCJGNVYPOGVAJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYQUINOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J2.960B","NSC-2039","NSC-285166","NSC-402623","NSC-48037","NSC-54230","NSC-615011","NSC-82404","NSC-82405","NSC-82409","NSC-82410","NSC-82412","Oxine","Oxyquinol","Oxyquinoline"],"crossReferences":{"PubChem":["144064","144206634","144210184","144213967","17389213","17389852","24724293","26752756","49826123","68737"],"Wikipedia":["8-Hydroxyquinoline"],"drugbank":["DB11145"],"chEBI":["48981"]},"childChemblIds":["CHEMBL1697698","CHEMBL3251402","CHEMBL451260","CHEMBL1366480","CHEMBL3186026"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL315838","canonicalSmiles":"COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1","inchiKey":"PJWPNDMDCLXCOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCAINIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"],"classes":["Cardiotoxicity"],"year":1991},"tradeNames":[],"synonyms":["Encainide"],"crossReferences":{"drugbank":["DB01228"],"chEBI":["4788"]},"childChemblIds":["CHEMBL2106155"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0004269"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986 and is indicated for cardiac arrhythmia. It was withdrawn in United Kingdom and  United States initially in 1991 due to Cardiotoxicity."}
{"id":"CHEMBL328139","canonicalSmiles":"C[C@H](O)[C@@H](CCc1cccc(Cl)c1Cl)n1cnc(C(N)=O)c1","inchiKey":"HCJYSIGJDKNVRU-TVQRCGJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL328139","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03370"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301618","canonicalSmiles":"CCCN(CCC)C(=O)C1=Cc2ccc(-c3ccc(C(=O)N4CCCC4)cc3)cc2N=C(N)C1","inchiKey":"QSPOQCXMGPDIHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOTOLIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Motolimod","VTX-2337","VTX-378"],"crossReferences":{"drugbank":["DB12303"]},"linkedTargets":{"rows":["ENSG00000101916"],"count":1},"linkedDiseases":{"rows":["EFO_1001967","MONDO_0002158","MONDO_0044787","EFO_0002938","EFO_0006352","MONDO_0015686","MONDO_0008170","EFO_0000574","EFO_0003871","EFO_0007535","EFO_0000707","EFO_0000181","MONDO_0044926"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3349607","canonicalSmiles":"NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O","inchiKey":"VMZMNAABQBOLAK-DBILLSOUSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL3349607","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06663"],"chEBI":["72312"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3426621","canonicalSmiles":"C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12","inchiKey":"QSKQVZWVLOIIEV-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIPASUDIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ripasudil"],"crossReferences":{"drugbank":["DB13165"]},"childChemblIds":["CHEMBL4594454"],"linkedTargets":{"rows":["ENSG00000134318","ENSG00000067900"],"count":2},"linkedDiseases":{"rows":["Orphanet_98974"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3544968","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-610677","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk-610677"],"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545069","drugType":"Unknown","blackBoxWarning":false,"name":"PELAREOREP","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Reolysin"],"synonyms":["PO BB0209","PO-BB-0209","PO-BB0209","Pelareorep","Reovirus 3 (strain dearing)","Reovirus type 3 (strain dearing)"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3545111","drugType":"Small molecule","blackBoxWarning":false,"name":"HEMAY-022","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hemay-022"],"linkedTargets":{"rows":["ENSG00000141736"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545140","drugType":"Small molecule","blackBoxWarning":false,"name":"QC-12","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Qc-12"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545148","drugType":"Small molecule","blackBoxWarning":false,"name":"PHE377","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phe377"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545351","canonicalSmiles":"Nc1cc(Cl)ccc1C(=O)CC(N)C(=O)O","inchiKey":"HQLHZNDJQSRKDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AV-101","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-chlorokynurenine","4-cl-kyn","Av-101","J578.071C","L-4-chlorokynurenine","L-4-cl-kyn"],"linkedTargets":{"rows":["ENSG00000161509","ENSG00000273079","ENSG00000116032","ENSG00000183454","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0005762","EFO_0001361","MONDO_0002050","MONDO_0002009"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL366460","canonicalSmiles":"O=c1c(-c2ccccc2)coc2ccccc12","inchiKey":"GOMNOOKGLZYEJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOFLAVONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isoflavone","NSC-135405"],"crossReferences":{"drugbank":["DB12007"],"chEBI":["18220"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3707313","canonicalSmiles":"CC(C)(C)c1cc(-c2cc(-c3ccc(C(=O)O)cc3)ccc2OCCO)ccc1N1CCCC1","inchiKey":"MFBCDACCJCDGBA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIFAROTENE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aklief"],"synonyms":["CD-5789","CD5789","Trifarotene"],"crossReferences":{"DailyMed":["trifarotene"],"drugbank":["DB12808"]},"linkedTargets":{"rows":["ENSG00000172819"],"count":1},"linkedDiseases":{"rows":["Orphanet_313","EFO_0000574","EFO_0003894"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for acne and has 2 investigational indications."}
{"id":"CHEMBL3707373","canonicalSmiles":"CN[C@H](C)CCC=C(C)C.CN[C@H](C)CCC=C(C)C.O=C(O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(=O)O","inchiKey":"WSXKZIDINJKWPM-PPPDGRNVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXISOMETHEPTENE MUCATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1476245","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexisometheptene mucate","TNX-201"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3833320","drugType":"Antibody","blackBoxWarning":false,"name":"EPTINEZUMAB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vyepti"],"synonyms":["ALD-403","ALD403","Eptinezumab","Eptinezumab-jjmr"],"crossReferences":{"DailyMed":["eptinezumab-jjmr"]},"linkedTargets":{"rows":["ENSG00000110680","ENSG00000175868"],"count":2},"linkedDiseases":{"rows":["MONDO_0005277","EFO_0003843"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for migraine disorder and has 1 investigational indication."}
{"id":"CHEMBL398440","canonicalSmiles":"Cc1cc(O)cc(C)c1Cl","inchiKey":"OSDLLIBGSJNGJE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROXYLENOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chloroxylenol","NSC-4971","P-chloro-m-xylenol","Parachlorometoxylenol"],"crossReferences":{"PubChem":["11532857","144204858","144212364","170465503","26747913","26753722"],"Wikipedia":["Chloroxylenol"],"drugbank":["DB11121"],"chEBI":["34393"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for inflammation."}
{"id":"CHEMBL3991241","drugType":"Small molecule","blackBoxWarning":false,"name":"FERRIC CITRATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["ferric%20citrate"]},"childChemblIds":["CHEMBL3301597"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved indications."}
{"id":"CHEMBL402001","canonicalSmiles":"O=P(O)(O)OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O","inchiKey":"NBSCHQHZLSJFNQ-PQMKYFCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MANNOSE-6-PHOSPHATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Juvidex","Mannose 6-phosphate","Mannose-6-phosphate"],"crossReferences":{"drugbank":["DB02900"],"chEBI":["43896"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL404520","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12","inchiKey":"CYDMQBQPVICBEU-XRNKAMNCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORTETRACYCLINE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chlorotetracycline","Chlortetracycline","E702"],"crossReferences":{"drugbank":["DB09093"],"chEBI":["27644"]},"childChemblIds":["CHEMBL2146100","CHEMBL2146063","CHEMBL2106006"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL4297336","canonicalSmiles":"C[11C](=O)O","inchiKey":"QTBSBXVTEAMEQO-JVVVGQRLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETIC ACID C-11","maximumClinicalTrialPhase":2,"parentId":"CHEMBL539","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(11c)acetic acid","11c-acetate","Acetic acid c-11","Acetic-1-11c acid","C-11 acetate"],"crossReferences":{"drugbank":["DB15111"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297369","canonicalSmiles":"CC(=O)Nc1ccc(C(=O)NC(C)(C)C)cc1","inchiKey":"DJKNRCWSXSZACF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP1-1189","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CPI-1189","Cp1-1189","Cpi-1189"],"crossReferences":{"drugbank":["DB12311"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297496","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)OCC(CSSc1ccc(COC(=O)N2[C@H]3CN4C5=C(C(=O)C(N)=C(C)C5=O)[C@@H](COC(N)=O)[C@@]4(OC)[C@H]32)cc1)OC(=O)CCCCCCCCCCCCCCCCC","inchiKey":"LIHIIWJRSSLKKX-YCTALCSSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-27548547","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-27548547","Jnj-27548547","Mmc lipid-based prodrug (mlp)","Promitil"],"crossReferences":{"drugbank":["DB15372"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297540","canonicalSmiles":"N#CCCCSC(=N)N","inchiKey":"PRDJGNVQBVXXEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-ISOTHIOUREIDOBUTYRONITRILE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-isothioureidobutyronitrile","Kevetrin","NSC-525990","Thioureidobutyronitrile"],"crossReferences":{"drugbank":["DB13010"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297595","canonicalSmiles":"N#CCCNc1nonc1-c1nc2ccccc2n1CC(=O)c1ccc(NC(=O)[C@@H](N)CCCCN)cc1","inchiKey":"NIPZLALJRAHABJ-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LISAVANBULIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAL 101553","BAL-101553","BAL101553","Bal101553","Lisavanbulin","MICROTUBULE-TARGETED AGENT BAL101553","Microtubule-targeted agent bal101553"],"crossReferences":{"drugbank":["DB15224"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297606","canonicalSmiles":"COc1ccc(-c2cc(=O)c3c(OC)cc(OCC(=O)O)cc3o2)cc1OC","inchiKey":"BCPQOBQIVJZOFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RECOFLAVONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DA 6034","DA-6034","Da-6034","Recoflavone"],"crossReferences":{"drugbank":["DB12058"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297802","drugType":"Enzyme","blackBoxWarning":true,"name":"PEGVALIASE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Palynziq"],"synonyms":["BMN 165","BMN-165","Bmn 165","Peg pal","Pegvaliase","Pegvaliase-pqpz","Phenylase"],"crossReferences":{"DailyMed":["pegvaliase-pqpz"]},"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for phenylketonuria. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4298031","drugType":"Antibody","blackBoxWarning":false,"name":"GREMUBAMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gremubamab","MEDI-3902","MEDI3902","Medi 3902","Medi3902"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298194","drugType":"Gene","blackBoxWarning":false,"name":"GIROCTOCOGENE FITELPARVOVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Giroctocogene fitelparvovec","PF-07055480","SB-525"],"linkedTargets":{"rows":["ENSG00000185010"],"count":1},"linkedDiseases":{"rows":["Orphanet_98878"],"count":1},"description":"Gene drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4300244","drugType":"Small molecule","blackBoxWarning":false,"name":"SAMARIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Samarium"],"childChemblIds":["CHEMBL4297426"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL445332","canonicalSmiles":"COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@H](c3ccoc3)C[C@]21C","inchiKey":"OBSYBRPAKCASQB-AGQYDFLVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SALVINORIN A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-salvinorin a","Divinorin a","Salvinorin","Salvinorin a"],"crossReferences":{"PubChem":["26755778","29216411"],"Wikipedia":["Salvinorin_A"],"drugbank":["DB12327"],"chEBI":["67900"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL44657","canonicalSmiles":"COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O","inchiKey":"VJJPUSNTGOMMGY-MRVIYFEKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ETOPOSIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Etoposide","Toposar","Vepesid"],"synonyms":["Etoposide","Etoposide resolution mixture","Etoposidum","NSC-141540","Sintopozid","VP-16-213"],"crossReferences":{"DailyMed":["etoposide"],"PubChem":["164339423","56463308"],"TG-GATEs":["131"],"Wikipedia":["Etoposide"],"drugbank":["DB00773"],"chEBI":["4911"]},"linkedTargets":{"rows":["ENSG00000131747","ENSG00000077097"],"count":2},"linkedDiseases":{"rows":["EFO_1000419","EFO_0000637","EFO_0011061","EFO_0000558","MONDO_0003751","MONDO_0002730","EFO_0005952","EFO_1001052","EFO_0000632","MONDO_0015760","EFO_0000339","EFO_0000096","MONDO_0008903","EFO_0002918","MONDO_0020574","EFO_0000514","EFO_0004991","EFO_1000028","MONDO_0002601","EFO_0000198","EFO_0000221","EFO_0002618","MONDO_0013730","MONDO_0019465","EFO_0000180","EFO_1000574","EFO_1001968","EFO_1001946","EFO_0009538","MONDO_0008315","EFO_0000630","EFO_1001365","EFO_0003028","EFO_0003032","MONDO_0044889","MONDO_0018201","EFO_0009254","EFO_1000527","MONDO_0019472","EFO_0008524","EFO_0000574","EFO_0004256","EFO_0001378","EFO_1000796","EFO_1000550","MONDO_0015564","MONDO_0018171","EFO_0007498","EFO_0007416","EFO_1001465","MONDO_0007254","Orphanet_790","MONDO_0004095","MONDO_0003541","MONDO_0001056","MONDO_0002158","EFO_1000565","EFO_0004289","EFO_0000326","EFO_0002499","EFO_0000183","MONDO_0002083","MONDO_0002618","MONDO_0003478","EFO_0000616","EFO_0005088","EFO_1001779","EFO_0000765","Orphanet_59305","MONDO_0019457","MONDO_0024503","EFO_0000403","EFO_0000222","MONDO_0000870","EFO_0003929","EFO_0004599","MONDO_0021657","EFO_1001471","MONDO_0002120","EFO_0000702","EFO_1001947","MONDO_0002367","MONDO_0018906","MONDO_0019004","MONDO_0024880","EFO_0000519","MONDO_0000873","EFO_0005543","EFO_0004281","EFO_0005783","EFO_0000571","MONDO_0000956","EFO_0002426","EFO_0000565","EFO_0000309","EFO_0004251","HP_0001871","EFO_0000182","EFO_0000330","MONDO_0015540","MONDO_0003001","Orphanet_654","EFO_0003802","EFO_0009441","EFO_1000292","EFO_0000220","EFO_0000248","MONDO_0008170","EFO_1000157","EFO_0005842","EFO_0002939","EFO_0000223","EFO_0000502","EFO_0002500","MONDO_0044881","EFO_0003025","MONDO_0100096","MONDO_0000386","MONDO_0021193","MONDO_0044917","EFO_0002428","EFO_0000233","EFO_0000218","EFO_0000563","MONDO_0009348","EFO_0003812","MONDO_0019471","MONDO_0044887","EFO_1001945","EFO_1001469","EFO_0000209","EFO_0000708","MONDO_0016700","MONDO_0002087","MONDO_0016691","EFO_0007362","MONDO_0021364","MONDO_0001475","MONDO_0001657","EFO_0002626","MONDO_0020743","EFO_1000158","EFO_1000415","MONDO_0021656","EFO_0000437","EFO_0000313","EFO_0002501","MONDO_0016717","EFO_0000621","EFO_0003029","EFO_0003060","EFO_0000311","EFO_1001383","EFO_0000211","EFO_1000437","EFO_1000564","EFO_1000581","EFO_0000095","EFO_0000174","EFO_0005235","EFO_0006475","EFO_1001936","EFO_1002008","MONDO_0020077","EFO_0003833","EFO_0000691","EFO_0003027","EFO_0003811"],"count":168},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for neoplasm and cancer and has 130 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4594598","drugType":"Unknown","blackBoxWarning":false,"name":"EFTRENONACOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alprolix","BIIB-029","Eftrenonacog alfa","Rfixfc"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594619","drugType":"Small molecule","blackBoxWarning":false,"name":"TECHNETIUM SESTAMIBI","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["technetium%20tc-99m%20sestamibi%20kit"]},"childChemblIds":["CHEMBL4594241","CHEMBL4594240"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for coronary artery disease."}
{"id":"CHEMBL4650274","drugType":"Unknown","blackBoxWarning":false,"name":"DASIGLUCAGON HYDROCHLORIDE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zegalogue","Zegalogue (autoinjector)"],"synonyms":["Dasiglucagon hydrochloride"],"linkedTargets":{"rows":["ENSG00000215644"],"count":1},"linkedDiseases":{"rows":["MONDO_0005147","HP_0001943"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for type 1 diabetes mellitus and hypoglycemia."}
{"id":"CHEMBL4650409","drugType":"Antibody","blackBoxWarning":false,"name":"NIVATROTAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HU3F8-BSAB","Nivatrotamab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL507795","canonicalSmiles":"CC1=CCC(O)(C(C)C)CC1","inchiKey":"WRYLYDPHFGVWKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERPINEOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Terpineol"],"crossReferences":{"PubChem":["144212102"],"Wikipedia":["Terpinen-4-ol","Terpineol"],"drugbank":["DB12816"],"chEBI":["78884"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL544665","canonicalSmiles":"CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1.Cl","inchiKey":"SWZTYAVBMYWFGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FINGOLIMOD HYDROCHLORIDE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL314854","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gilenya"],"synonyms":["FTY-720 HYDROCHLORIDE","FTY720","FTY720 HYDROCHLORIDE","Fingolimod","Fingolimod (as hydrochloride)","Fingolimod hcl","Fingolimod hydrochlorid","Fingolimod hydrochloride","Gilenia"],"crossReferences":{"DailyMed":["fingolimod%20hydrochloride"],"chEBI":["63112"]},"linkedTargets":{"rows":["ENSG00000170989","ENSG00000180739","ENSG00000267534","ENSG00000213694","ENSG00000125910"],"count":5},"linkedDiseases":{"rows":["MONDO_0005301","EFO_0003929","MONDO_0004976","EFO_0000305"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for multiple sclerosis and has 3 investigational indications."}
{"id":"CHEMBL552212","canonicalSmiles":"CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1","inchiKey":"MTJHLONVHHPNSI-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEXIBULIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CYT 997","CYT-997","CYT997","Lexibulin"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000137285","ENSG00000123416","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_0001378","EFO_0000519"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL557915","canonicalSmiles":"O=C(CN1CC[C@@H](NC(=O)c2ccc(Cl)s2)C1)Nc1ccc(-n2ccccc2=O)cc1F","inchiKey":"IYGIXVNAMZPBDK-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL557915","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07872"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL56053","canonicalSmiles":"CC[C@@H](C)[C@H](N)C(=O)O","inchiKey":"AGPKZVBTJJNPAG-UHNVWZDZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL56053","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205857"],"drugbank":["DB01739"],"chEBI":["43433"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL56190","canonicalSmiles":"CNc1nc(N)[nH]c(=O)c1[N+](=O)[O-]","inchiKey":"NMCMUSAXKISTKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL56190","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03705"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL604","drugType":"Small molecule","blackBoxWarning":false,"name":"CUPRIC SULFATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Caustic Powder","Copper Sulfate","Cupric sulfate"],"synonyms":["Copper (as cupric sulfate)","Copper (as sulfate)","Copper sulfate","Copper sulfate, anhydrous","Copper(ii) sulfate, anhydrous","Copper(ii) tetraoxosulfate","Cupric Sulfate","Cupric sulfate","Cupric sulfate anhydrous","Cupric sulfate pentahydrate","Cupric sulfate, anhydrous","Cupric sulfate,anhydrous","Cupric sulphate","Cupric sulphate anhydrous","Cupric sulphate pentahydrate","Cupric sulphate, anhydrous","Cuprum sulphuricum","E519","NSC-57630"],"crossReferences":{"DrugCentral":["4282"],"Wikipedia":["Copper(II)_sulfate"],"chEBI":["23414"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 3 approved indications."}
{"id":"CHEMBL609880","canonicalSmiles":"C[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O","inchiKey":"SHZGCJCMOBCMKK-PHYPRBDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Alpha-D-Fucopyranose","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha-D-Fucopyranose"],"crossReferences":{"drugbank":["DB03485"],"chEBI":["42564"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL648","canonicalSmiles":"CN1CCN(C(c2ccccc2)c2ccccc2)CC1","inchiKey":"UVKZSORBKUEBAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLIZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cyclizine","Marezine","NSC-26608"],"crossReferences":{"PubChem":["11112316","124882239","26747952"],"Wikipedia":["Cyclizine"],"drugbank":["DB01176"],"chEBI":["3994"]},"childChemblIds":["CHEMBL1324714","CHEMBL3189137","CHEMBL1200497"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["MONDO_0005271"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for allergic disease."}
{"id":"CHEMBL65375","canonicalSmiles":"Cl.N=C1CCCN1Cc1[nH]c(=O)[nH]c(=O)c1Cl","inchiKey":"KGHYQYACJRXCAT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIPIRACIL HYDROCHLORIDE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL235668","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["TAS-1-462","TPI","Tipiracil hydrochloride"],"crossReferences":{"DailyMed":["tipiracil%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000025708"],"count":1},"linkedDiseases":{"rows":["EFO_1001480","EFO_0000365","EFO_1000657","MONDO_0044937"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for colorectal adenocarcinoma and has 2 investigational indications."}
{"id":"CHEMBL675","canonicalSmiles":"NCCCC(O)(P(=O)([O-])O)P(=O)(O)O.[Na+]","inchiKey":"CAKRAHQRJGUPIG-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ALENDRONATE SODIUM","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL870","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alendronate sodium","Binosto","Fosamax"],"synonyms":["Adrovance","Alendronate (as sodium)","Alendronate sodium","Alendronate sodium hydrate","Alendronate sodium trihydrate","Alendronic acid monosodium salt trihydrate","Fosavance","G-704,650","G-704650","MK-217","NSC-722597","NSC-758931","Sodium alendronate","Sodium alendronate trihydrate","Vantavo"],"crossReferences":{"DailyMed":["alendronate%20sodium"]},"linkedTargets":{"rows":["ENSG00000160752"],"count":1},"linkedDiseases":{"rows":["EFO_0000589","EFO_0004261","EFO_0011061","EFO_0003854","MONDO_0007254","EFO_0003762","EFO_0003882","MONDO_0005178"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL696","canonicalSmiles":"CCC1(C)CC(=O)NC1=O","inchiKey":"HAPOVYFOVVWLRS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHOSUXIMIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emeside","Ethosuximide","Suxinutin","Zarontin"],"synonyms":["CI-366","CN-10,395","CN-10395","Ethosuximide","Ethosuximidum","NSC-64013","PM-671","Pyknolepsinum"],"crossReferences":{"DailyMed":["ethosuximide"],"PubChem":["144203921","170464802","174006922","26747515","26747516","50106318","50106319","85231037","90340672"],"Wikipedia":["Ethosuximide"],"drugbank":["DB00593"],"chEBI":["4887"]},"linkedTargets":{"rows":["ENSG00000100346","ENSG00000006283","ENSG00000196557"],"count":3},"linkedDiseases":{"rows":["EFO_0005762","MONDO_0005277","EFO_1001998","EFO_0000474","MONDO_0002050","EFO_0000555","HP_0001250","Orphanet_64280"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and is indicated for epilepsy and has 7 investigational indications."}
{"id":"CHEMBL74926","canonicalSmiles":"CN1CC[C@@]2(C)c3cc(OC(=O)Nc4ccccc4)ccc3N(C)[C@@H]12","inchiKey":"PBHFNBQPZCRWQP-QUCCMNQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENSERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenserine"],"crossReferences":{"PubChem":["26756608","90341153"],"drugbank":["DB04892"]},"childChemblIds":["CHEMBL123249"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL754","canonicalSmiles":"O=C([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+]","inchiKey":"DFHAXXVZCFXGOQ-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":true,"name":"FOSCARNET SODIUM","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL666","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Foscarnet sodium","Foscavir"],"synonyms":["A-29622","EHB 776","EHB-776","Foscarnet sodium","Foscarnet sodium anhydrous","Foscarnet sodium hexahydrate","Foscarnet sodium hydrate","Foscarnet trisodium hexahydrate","Foscavir","NSC-313410","NSC-758148"],"crossReferences":{"DailyMed":["foscarnet%20sodium"],"PubChem":["144204917","170465060","26748573"],"chEBI":["141644"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 3 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL91","canonicalSmiles":"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1","inchiKey":"BYBLEWFAAKGYCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MICONAZOLE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Conofite","Dermazole","Dumicoat","Loramyc","Micatin","Monistat","Monistat-3","Monistat-Derm","Oravig"],"synonyms":["Miconazole","Monistat-Derm","NSC-170986","Vusion"],"crossReferences":{"DailyMed":["miconazole","miconazole%20nitrate"],"PubChem":["144204152","443253","85148356"],"Wikipedia":["Miconazole"],"drugbank":["DB01110"],"chEBI":["82892"]},"childChemblIds":["CHEMBL1559","CHEMBL4578119"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 5 approved and 5 investigational indications."}
{"id":"CHEMBL989","canonicalSmiles":"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1","inchiKey":"FEBLZLNTKCEFIT-VSXGLTOVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOCINOLONE ACETONIDE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Capex","Derma-smoothe/fs","Dermotic","Fluocet","Fluocinolone acetonide","Fluonid","Fluotrex","Fs shampoo","Iluvien","Retisert","Synalar","Synalar fte","Synalar-c","Synalar-hp","Synalar-n","Synandone","Yutiq"],"synonyms":["Flucinolone acetonide","Fluocinolide (acetate)","Fluocinolone","Fluocinolone acetonide","NSC-92339","Oto-synalar"],"crossReferences":{"DailyMed":["fluocinolone%20acetonide"],"PubChem":["144204420","144212681","170464630","29214997","398387","56422130","855535"],"Wikipedia":["Fluocinolone_acetonide"],"drugbank":["DB00591"],"chEBI":["31623"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["MONDO_0003005","EFO_1001494","EFO_0001365","EFO_0003963","EFO_1000764","EFO_0000701","MONDO_0005271","EFO_0000274","EFO_1001119","EFO_0009606","EFO_1001231","EFO_0005741","EFO_0009560","MONDO_0021666","EFO_0003839","EFO_0000676","EFO_0009552","EFO_0000516","EFO_0009321","EFO_0005752"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and has 10 approved and 6 investigational indications."}
